HEADER HYDROLASE 20-JUL-12 4B36 TITLE CRYSTAL STRUCTURE OF HUMAN ANGIOGENIN WITH AN ENGINEERED LOOP EXHIBITS TITLE 2 CONFORMATIONAL FLEXIBILITY AT THE FUNCTIONAL REGIONS OF THE MOLECULE COMPND MOL_ID: 1; COMPND 2 MOLECULE: ANGIOGENIN, EOSINOPHIL CATIONIC-RELATED PROTEIN; COMPND 3 CHAIN: A, B; COMPND 4 FRAGMENT: RESIDUES 25-107,111-120,116-147; COMPND 5 SYNONYM: RIBONUCLEASE 5, RNASE 5, ANGIOGENIN-EOSINOPHIL DERIVED COMPND 6 NEUROTOXIN HYBRID; COMPND 7 EC: 3.1.27.-; COMPND 8 ENGINEERED: YES; COMPND 9 OTHER_DETAILS: IN THIS STUDY WE HAVE SUBSTITUTED 84- HGGSPWPP-91 OF COMPND 10 ANG WITH 86-TTPSPQNISN-95 OF EOSINOPHIL- DERIVED NEUROTOXIN AND COMPND 11 CONSTRUCTED AN ANG-EDN HYBRID SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 6 EXPRESSION_SYSTEM_TAXID: 469008; SOURCE 7 EXPRESSION_SYSTEM_STRAIN: BL21(DE3); SOURCE 8 EXPRESSION_SYSTEM_VARIANT: CODON PLUS RIPL; SOURCE 9 EXPRESSION_SYSTEM_VECTOR_TYPE: PLASMID; SOURCE 10 EXPRESSION_SYSTEM_PLASMID: PET22B PLUS KEYWDS HYDROLASE, EDN, ANG, ANTIVIRAL, ANGIOGENESIS, TUMOR, AMYOTROPHIC KEYWDS 2 LATERAL SCLEROSIS, PARKINSONS DISEASE EXPDTA X-RAY DIFFRACTION AUTHOR N.THIYAGARAJAN,K.R.ACHARYA REVDAT 4 20-DEC-23 4B36 1 REMARK REVDAT 3 26-JUN-13 4B36 1 JRNL REVDAT 2 16-JAN-13 4B36 1 JRNL REVDAT 1 26-DEC-12 4B36 0 JRNL AUTH N.THIYAGARAJAN,K.R.ACHARYA JRNL TITL CRYSTAL STRUCTURE OF HUMAN ANGIOGENIN WITH AN ENGINEERED JRNL TITL 2 LOOP EXHIBITS CONFORMATIONAL FLEXIBILITY AT THE FUNCTIONAL JRNL TITL 3 REGIONS OF THE MOLECULE JRNL REF FEBS OPEN BIO. V. 3 65 2012 JRNL REFN ESSN 2211-5463 JRNL PMID 23772376 JRNL DOI 10.1016/J.FOB.2012.12.003 REMARK 2 REMARK 2 RESOLUTION. 1.76 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : PHENIX (PHENIX.REFINE) REMARK 3 AUTHORS : PAUL ADAMS,PAVEL AFONINE,VINCENT CHEN,IAN REMARK 3 : DAVIS,KRESHNA GOPAL,RALF GROSSE-KUNSTLEVE, REMARK 3 : LI-WEI HUNG,ROBERT IMMORMINO,TOM IOERGER, REMARK 3 : AIRLIE MCCOY,ERIK MCKEE,NIGEL MORIARTY, REMARK 3 : REETAL PAI,RANDY READ,JANE RICHARDSON, REMARK 3 : DAVID RICHARDSON,TOD ROMO,JIM SACCHETTINI, REMARK 3 : NICHOLAS SAUTER,JACOB SMITH,LAURENT REMARK 3 : STORONI,TOM TERWILLIGER,PETER ZWART REMARK 3 REMARK 3 REFINEMENT TARGET : ML REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 1.76 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 20.15 REMARK 3 MIN(FOBS/SIGMA_FOBS) : 0.100 REMARK 3 COMPLETENESS FOR RANGE (%) : 89.3 REMARK 3 NUMBER OF REFLECTIONS : 18214 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 R VALUE (WORKING + TEST SET) : 0.239 REMARK 3 R VALUE (WORKING SET) : 0.237 REMARK 3 FREE R VALUE : 0.285 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 5.100 REMARK 3 FREE R VALUE TEST SET COUNT : 933 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT (IN BINS). REMARK 3 BIN RESOLUTION RANGE COMPL. NWORK NFREE RWORK RFREE REMARK 3 1 20.1519 - 3.3625 0.81 2397 112 0.2387 0.2349 REMARK 3 2 3.3625 - 2.6709 0.94 2620 123 0.2347 0.3134 REMARK 3 3 2.6709 - 2.3339 0.97 2687 158 0.2450 0.3021 REMARK 3 4 2.3339 - 2.1207 0.98 2652 151 0.2172 0.3288 REMARK 3 5 2.1207 - 1.9689 0.97 2634 162 0.2131 0.2611 REMARK 3 6 1.9689 - 1.8529 0.92 2515 136 0.2350 0.3175 REMARK 3 7 1.8529 - 1.7601 0.66 1776 91 0.2575 0.3677 REMARK 3 REMARK 3 BULK SOLVENT MODELLING. REMARK 3 METHOD USED : FLAT BULK SOLVENT MODEL REMARK 3 SOLVENT RADIUS : 1.11 REMARK 3 SHRINKAGE RADIUS : 0.90 REMARK 3 K_SOL : 0.43 REMARK 3 B_SOL : 58.58 REMARK 3 REMARK 3 ERROR ESTIMATES. REMARK 3 COORDINATE ERROR (MAXIMUM-LIKELIHOOD BASED) : 0.180 REMARK 3 PHASE ERROR (DEGREES, MAXIMUM-LIKELIHOOD BASED) : 28.230 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : 27.12 REMARK 3 MEAN B VALUE (OVERALL, A**2) : NULL REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : 4.88450 REMARK 3 B22 (A**2) : -8.31030 REMARK 3 B33 (A**2) : 3.42580 REMARK 3 B12 (A**2) : 0.00000 REMARK 3 B13 (A**2) : 0.00000 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 TWINNING INFORMATION. REMARK 3 FRACTION: NULL REMARK 3 OPERATOR: NULL REMARK 3 REMARK 3 DEVIATIONS FROM IDEAL VALUES. REMARK 3 RMSD COUNT REMARK 3 BOND : 0.007 1859 REMARK 3 ANGLE : 1.012 2495 REMARK 3 CHIRALITY : 0.067 273 REMARK 3 PLANARITY : 0.006 328 REMARK 3 DIHEDRAL : 13.283 704 REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : NULL REMARK 3 REMARK 3 NCS DETAILS REMARK 3 NUMBER OF NCS GROUPS : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 4B36 COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY PDBE ON 20-JUL-12. REMARK 100 THE DEPOSITION ID IS D_1290053431. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 04-NOV-06 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : NULL REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : SRS REMARK 200 BEAMLINE : PX10.1 REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 1.283 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : MIRRORS REMARK 200 REMARK 200 DETECTOR TYPE : CCD REMARK 200 DETECTOR MANUFACTURER : MARMOSAIC 225 MM CCD REMARK 200 INTENSITY-INTEGRATION SOFTWARE : HKL-2000 REMARK 200 DATA SCALING SOFTWARE : HKL-2000 REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 20481 REMARK 200 RESOLUTION RANGE HIGH (A) : 1.760 REMARK 200 RESOLUTION RANGE LOW (A) : 50.000 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : 0.000 REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 91.9 REMARK 200 DATA REDUNDANCY : 4.800 REMARK 200 R MERGE (I) : 0.08000 REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : 14.5000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 1.76 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 1.82 REMARK 200 COMPLETENESS FOR SHELL (%) : 65.8 REMARK 200 DATA REDUNDANCY IN SHELL : 2.50 REMARK 200 R MERGE FOR SHELL (I) : 0.30000 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : 2.900 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: PHASER REMARK 200 STARTING MODEL: PDB ENTRY 1ANG REMARK 200 REMARK 200 REMARK: NONE REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 32.20 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 1.81 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 1.75-2.5 M NACL REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 21 21 21 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X+1/2,-Y,Z+1/2 REMARK 290 3555 -X,Y+1/2,-Z+1/2 REMARK 290 4555 X+1/2,-Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 19.17650 REMARK 290 SMTRY2 2 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 47.36550 REMARK 290 SMTRY1 3 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 3 0.000000 1.000000 0.000000 27.33800 REMARK 290 SMTRY3 3 0.000000 0.000000 -1.000000 47.36550 REMARK 290 SMTRY1 4 1.000000 0.000000 0.000000 19.17650 REMARK 290 SMTRY2 4 0.000000 -1.000000 0.000000 27.33800 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1, 2 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: MONOMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 REMARK 350 BIOMOLECULE: 2 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: MONOMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 APPLY THE FOLLOWING TO CHAINS: B REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 MET A 0 REMARK 465 GLN A 1 REMARK 465 ASP A 2 REMARK 465 GLU A 58 REMARK 465 ASN A 59 REMARK 465 LYS A 60 REMARK 465 ASN A 61 REMARK 465 GLY A 62 REMARK 465 ARG A 124 REMARK 465 PRO A 125 REMARK 465 MET B 0 REMARK 465 GLN B 1 REMARK 465 ASP B 2 REMARK 465 ASN B 3 REMARK 465 ASN B 59 REMARK 465 LYS B 60 REMARK 465 ASN B 61 REMARK 465 GLY B 62 REMARK 465 PRO B 88 REMARK 465 GLN B 89 REMARK 465 ASN B 90 REMARK 465 ILE B 91 REMARK 465 SER B 92 REMARK 470 REMARK 470 MISSING ATOM REMARK 470 THE FOLLOWING RESIDUES HAVE MISSING ATOMS (M=MODEL NUMBER; REMARK 470 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; REMARK 470 I=INSERTION CODE): REMARK 470 M RES CSSEQI ATOMS REMARK 470 ASN A 3 CG OD1 ND2 REMARK 470 SER A 4 OG REMARK 470 ARG A 5 CG CD NE CZ NH1 NH2 REMARK 470 ARG A 123 CG CD NE CZ NH1 NH2 REMARK 470 HIS B 65 CG ND1 CD2 CE1 NE2 REMARK 470 PRO B 125 CA C O CB CG CD REMARK 480 REMARK 480 ZERO OCCUPANCY ATOM REMARK 480 THE FOLLOWING RESIDUES HAVE ATOMS MODELED WITH ZERO REMARK 480 OCCUPANCY. THE LOCATION AND PROPERTIES OF THESE ATOMS REMARK 480 MAY NOT BE RELIABLE. (M=MODEL NUMBER; RES=RESIDUE NAME; REMARK 480 C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE): REMARK 480 M RES C SSEQI ATOMS REMARK 480 GLN A 19 CD OE1 REMARK 480 ARG A 24 CG CZ NH1 REMARK 480 ASN A 63 CG ND2 REMARK 480 GLN A 89 OE1 REMARK 480 HIS A 116 CG ND1 CE1 REMARK 480 GLN B 19 NE2 REMARK 480 LYS B 73 CD REMARK 480 ASN B 93 CB OD1 REMARK 480 GLN B 95 CG REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 PRO A 64 -67.66 -104.76 REMARK 500 ASN A 90 56.73 -145.74 REMARK 500 ARG B 124 149.51 91.66 REMARK 500 REMARK 500 REMARK: NULL REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE CL B 1125 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE CL B 1126 REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 1A4Y RELATED DB: PDB REMARK 900 RIBONUCLEASE INHIBITOR-ANGIOGENIN COMPLEX REMARK 900 RELATED ID: 1ANG RELATED DB: PDB REMARK 900 ANGIOGENIN REMARK 900 RELATED ID: 1AWZ RELATED DB: PDB REMARK 900 3D SOLUTION STRUCTURE OF HUMAN ANGIOGENIN DETERMINED BY 1H, 15N NMR REMARK 900 SPECTROSCOPY, 30 STRUCTURES REMARK 900 RELATED ID: 1B1E RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF HUMAN ANGIOGENIN VARIANT K40Q REMARK 900 RELATED ID: 1B1I RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF HUMAN ANGIOGENIN REMARK 900 RELATED ID: 1B1J RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF HUMAN ANGIOGENIN VARIANT H13A. REMARK 900 RELATED ID: 1GV7 RELATED DB: PDB REMARK 900 GUEST-HOST CROSSTALK IN AN ANGIOGENIN/RNASE A CHIMERIC PROTEIN REMARK 900 RELATED ID: 1H0D RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF HUMAN ANGIOGENIN IN COMPLEX WITH FAB FRAGMENT REMARK 900 OF ITS MONOCLONAL ANTIBODY MAB 26-2F REMARK 900 RELATED ID: 1H52 RELATED DB: PDB REMARK 900 BINDING OF PHOSPHATE AND PYROPHOSPHATE IONS AT THE ACTIVE SITE OF REMARK 900 HUMAN ANGIOGENIN AS REVEALED BY X-RAY CRYSTALLOGRAPHY REMARK 900 RELATED ID: 1H53 RELATED DB: PDB REMARK 900 BINDING OF PHOSPHATE AND PYROPHOSPHATE IONS AT THE ACTIVE SITE OF REMARK 900 HUMAN ANGIOGENIN AS REVEALED BY X-RAY CRYSTALLOGRAPHY REMARK 900 RELATED ID: 1HBY RELATED DB: PDB REMARK 900 BINDING OF PHOSPHATE AND PYROPHOSPHATE IONS AT THE ACTIVE SITE OF REMARK 900 HUMAN ANGIOGENIN AS REVEALED BY X-RAY CRYSTALLOGRAPHY REMARK 900 RELATED ID: 1K58 RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF HUMAN ANGIOGENIN VARIANT D116H REMARK 900 RELATED ID: 1K59 RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF HUMAN ANGIOGENIN VARIANT Q117G REMARK 900 RELATED ID: 1K5A RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF HUMAN ANGIOGENIN DOUBLE VARIANTI119A /F120A REMARK 900 RELATED ID: 1K5B RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF HUMAN ANGIOGENIN VARIANT DES(121-123) REMARK 900 RELATED ID: 1UN3 RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF HUMAN ANGIOGENIN VARIANT T44D REMARK 900 RELATED ID: 1UN4 RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF HUMAN ANGIOGENIN VARIANT T80A REMARK 900 RELATED ID: 1UN5 RELATED DB: PDB REMARK 900 ARH-II, AN ANGIOGENIN/RNASE A CHIMERA REMARK 900 RELATED ID: 2ANG RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF HUMAN ANGIOGENIN OF THE MET(-1) FORM REMARK 900 RELATED ID: 4AHD RELATED DB: PDB REMARK 900 Q12L - ANGIOGENIN MUTANTS AND AMYOTROPHIC LATERAL SCLEROSIS - A REMARK 900 BIOCHEMICAL AND BIOLOGICAL ANALYSIS REMARK 900 RELATED ID: 4AHE RELATED DB: PDB REMARK 900 K17I - ANGIOGENIN MUTANTS AND AMYOTROPHIC LATERAL SCLEROSIS - A REMARK 900 BIOCHEMICAL AND BIOLOGICAL ANALYSIS REMARK 900 RELATED ID: 4AHF RELATED DB: PDB REMARK 900 K17E - ANGIOGENIN MUTANTS AND AMYOTROPHIC LATERAL SCLEROSIS - A REMARK 900 BIOCHEMICAL AND BIOLOGICAL ANALYSIS REMARK 900 RELATED ID: 4AHG RELATED DB: PDB REMARK 900 S28N - ANGIOGENIN MUTANTS AND AMYOTROPHIC LATERAL SCLEROSIS - A REMARK 900 BIOCHEMICAL AND BIOLOGICAL ANALYSIS REMARK 900 RELATED ID: 4AHH RELATED DB: PDB REMARK 900 R31K - ANGIOGENIN MUTANTS AND AMYOTROPHIC LATERAL SCLEROSIS - A REMARK 900 BIOCHEMICAL AND BIOLOGICAL ANALYSIS REMARK 900 RELATED ID: 4AHI RELATED DB: PDB REMARK 900 K40I - ANGIOGENIN MUTANTS AND AMYOTROPHIC LATERAL SCLEROSIS - A REMARK 900 BIOCHEMICAL AND BIOLOGICAL ANALYSIS REMARK 900 RELATED ID: 4AHJ RELATED DB: PDB REMARK 900 I46V - ANGIOGENIN MUTANTS AND AMYOTROPHIC LATERAL SCLEROSIS - A REMARK 900 BIOCHEMICAL AND BIOLOGICAL ANALYSIS REMARK 900 RELATED ID: 4AHK RELATED DB: PDB REMARK 900 K54E - ANGIOGENIN MUTANTS AND AMYOTROPHIC LATERAL SCLEROSIS - A REMARK 900 BIOCHEMICAL AND BIOLOGICAL ANALYSIS REMARK 900 RELATED ID: 4AHL RELATED DB: PDB REMARK 900 P112L - ANGIOGENIN MUTANTS AND AMYOTROPHIC LATERAL SCLEROSIS - A REMARK 900 BIOCHEMICAL AND BIOLOGICAL ANALYSIS REMARK 900 RELATED ID: 4AHM RELATED DB: PDB REMARK 900 V113I - ANGIOGENIN MUTANTS AND AMYOTROPHIC LATERAL SCLEROSIS - A REMARK 900 BIOCHEMICAL AND BIOLOGICAL ANALYSIS REMARK 900 RELATED ID: 4AHN RELATED DB: PDB REMARK 900 R121H - ANGIOGENIN MUTANTS AND AMYOTROPHIC LATERAL SCLEROSIS - A REMARK 900 BIOCHEMICAL AND BIOLOGICAL ANALYSIS REMARK 900 RELATED ID: 4AOH RELATED DB: PDB REMARK 900 STRUCTURAL SNAPSHOTS AND FUNCTIONAL ANALYSIS OF HUMAN ANGIOGENIN REMARK 900 VARIANTS ASSOCIATED WITH AMYOTROPHIC LATERAL SCLEROSIS (ALS) REMARK 999 REMARK 999 SEQUENCE REMARK 999 IN THIS STUDY WE HAVE SUBSTITUTED 84-HGGSPWPP-91 OF ANG REMARK 999 WITH 86-TTPSPQNISN-95 OF EOSINOPHIL-DERIVED NEUROTOXIN AND REMARK 999 CONSTRUCTED AN ANG-EDN HYBRID DBREF 4B36 A 1 83 UNP P03950 ANGI_HUMAN 25 107 DBREF 4B36 A 84 93 UNP Q12762 Q12762_HUMAN 111 120 DBREF 4B36 A 94 125 UNP P03950 ANGI_HUMAN 116 147 DBREF 4B36 B 1 83 UNP P03950 ANGI_HUMAN 25 107 DBREF 4B36 B 84 93 UNP Q12762 Q12762_HUMAN 111 120 DBREF 4B36 B 94 125 UNP P03950 ANGI_HUMAN 116 147 SEQADV 4B36 MET A 0 UNP P03950 EXPRESSION TAG SEQADV 4B36 MET B 0 UNP P03950 EXPRESSION TAG SEQRES 1 A 126 MET GLN ASP ASN SER ARG TYR THR HIS PHE LEU THR GLN SEQRES 2 A 126 HIS TYR ASP ALA LYS PRO GLN GLY ARG ASP ASP ARG TYR SEQRES 3 A 126 CYS GLU SER ILE MET ARG ARG ARG GLY LEU THR SER PRO SEQRES 4 A 126 CYS LYS ASP ILE ASN THR PHE ILE HIS GLY ASN LYS ARG SEQRES 5 A 126 SER ILE LYS ALA ILE CYS GLU ASN LYS ASN GLY ASN PRO SEQRES 6 A 126 HIS ARG GLU ASN LEU ARG ILE SER LYS SER SER PHE GLN SEQRES 7 A 126 VAL THR THR CYS LYS LEU THR THR PRO SER PRO GLN ASN SEQRES 8 A 126 ILE SER ASN CYS GLN TYR ARG ALA THR ALA GLY PHE ARG SEQRES 9 A 126 ASN VAL VAL VAL ALA CYS GLU ASN GLY LEU PRO VAL HIS SEQRES 10 A 126 LEU ASP GLN SER ILE PHE ARG ARG PRO SEQRES 1 B 126 MET GLN ASP ASN SER ARG TYR THR HIS PHE LEU THR GLN SEQRES 2 B 126 HIS TYR ASP ALA LYS PRO GLN GLY ARG ASP ASP ARG TYR SEQRES 3 B 126 CYS GLU SER ILE MET ARG ARG ARG GLY LEU THR SER PRO SEQRES 4 B 126 CYS LYS ASP ILE ASN THR PHE ILE HIS GLY ASN LYS ARG SEQRES 5 B 126 SER ILE LYS ALA ILE CYS GLU ASN LYS ASN GLY ASN PRO SEQRES 6 B 126 HIS ARG GLU ASN LEU ARG ILE SER LYS SER SER PHE GLN SEQRES 7 B 126 VAL THR THR CYS LYS LEU THR THR PRO SER PRO GLN ASN SEQRES 8 B 126 ILE SER ASN CYS GLN TYR ARG ALA THR ALA GLY PHE ARG SEQRES 9 B 126 ASN VAL VAL VAL ALA CYS GLU ASN GLY LEU PRO VAL HIS SEQRES 10 B 126 LEU ASP GLN SER ILE PHE ARG ARG PRO HET CL B1125 1 HET CL B1126 1 HETNAM CL CHLORIDE ION FORMUL 3 CL 2(CL 1-) FORMUL 5 HOH *85(H2 O) HELIX 1 1 ASN A 3 TYR A 14 1 12 HELIX 2 2 ASP A 22 ARG A 33 1 12 HELIX 3 3 ASN A 49 ALA A 55 1 7 HELIX 4 4 SER A 87 ILE A 91 5 5 HELIX 5 5 GLN A 119 ARG A 123 5 5 HELIX 6 6 SER B 4 TYR B 14 1 11 HELIX 7 7 ASP B 22 ARG B 33 1 12 HELIX 8 8 ASN B 49 GLU B 58 1 10 HELIX 9 9 GLN B 119 ARG B 123 5 5 SHEET 1 AA 3 ILE A 42 ILE A 46 0 SHEET 2 AA 3 PHE A 76 LEU A 83 -1 O THR A 79 N PHE A 45 SHEET 3 AA 3 TYR A 96 ARG A 103 -1 O ARG A 97 N LYS A 82 SHEET 1 AB 3 ASN A 68 ILE A 71 0 SHEET 2 AB 3 VAL A 106 GLU A 110 -1 O VAL A 107 N ARG A 70 SHEET 3 AB 3 LEU A 113 LEU A 117 -1 O LEU A 113 N GLU A 110 SHEET 1 BA 3 ILE B 42 ILE B 46 0 SHEET 2 BA 3 PHE B 76 LEU B 83 -1 O THR B 79 N PHE B 45 SHEET 3 BA 3 TYR B 96 ARG B 103 -1 O ARG B 97 N LYS B 82 SHEET 1 BB 3 ASN B 68 ILE B 71 0 SHEET 2 BB 3 VAL B 106 GLU B 110 -1 O VAL B 107 N ARG B 70 SHEET 3 BB 3 LEU B 113 LEU B 117 -1 O LEU B 113 N GLU B 110 SSBOND 1 CYS A 26 CYS A 81 1555 1555 2.04 SSBOND 2 CYS A 39 CYS A 94 1555 1555 2.02 SSBOND 3 CYS A 57 CYS A 109 1555 1555 2.03 SSBOND 4 CYS B 26 CYS B 81 1555 1555 2.02 SSBOND 5 CYS B 39 CYS B 94 1555 1555 2.03 SSBOND 6 CYS B 57 CYS B 109 1555 1555 2.04 CISPEP 1 SER A 37 PRO A 38 0 6.20 CISPEP 2 ASN A 63 PRO A 64 0 -2.63 CISPEP 3 SER B 37 PRO B 38 0 -2.73 CISPEP 4 ASN B 63 PRO B 64 0 -20.79 SITE 1 AC1 4 ARG A 32 ARG A 33 ARG B 32 ARG B 33 SITE 1 AC2 4 HIS B 13 ASN B 43 THR B 44 ARG B 123 CRYST1 38.353 54.676 94.731 90.00 90.00 90.00 P 21 21 21 8 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.026074 0.000000 0.000000 0.00000 SCALE2 0.000000 0.018290 0.000000 0.00000 SCALE3 0.000000 0.000000 0.010556 0.00000